Publicacions en què col·labora amb Alba Antúnez Rodríguez (10)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

    Biomedicine and Pharmacotherapy, Vol. 169

2022

  1. Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  2. Genetic polymorphisms affecting ranibizumab response in high myopia patients

    Pharmaceutics, Vol. 13, Núm. 11

  3. Identification of mirnas as viable aggressiveness biomarkers for prostate cancer

    Biomedicines, Vol. 9, Núm. 6

  4. Pharmacogenetic polymorphisms affecting bisoprolol response

    Biomedicine and Pharmacotherapy, Vol. 142

2020

  1. Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis

    Genes, Vol. 11, Núm. 11, pp. 1-13

  2. Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer

    Science of the Total Environment, Vol. 730

2019

  1. Pharmacogenetics in the Treatment of Cardiovascular Diseases and its current progress regarding Implementation in the Clinical Routine

    Genes, Vol. 10, Núm. 4